Novocure’s Pancreatic Cancer Treatment Meets Main Goal in Late-stage Study
(Reuters) - Novocure stated on Monday its speculative treatment extended the lives of clients with a type of sophisticated pancreatic cancer when integrated with chemotherapy, attaining the main objective in a late-stage trial.
The treatment utilizes Tumor Treating Fields, or electrical fields, to eliminate cancer cells while sparing most neighboring healthy cells, utilizing a portable gadget put on the skin near the growth.
In the research study, TTFields treatment concomitant with chemotherapy assisted clients live for approximately 16.20 months, compared to 14.16 months in clients treated with chemotherapy alone, Novocure stated.
The treatment's security followed previous scientific research studies, the business stated.
The treat...